U.S. Appeals Court Rules Glenmark Owes Abbott $25 Million In Patent Case
This article was originally published in PharmAsia News
A U.S. appeals court ruled against Glenmark Pharmaceuticals in a patent-infringement case involving hypertension drug Tarka (trandolapril/verapamil) made by Abbott Laboratories.
You may also be interested in...
The $250m deal adds A&E Medical’s sternal sutures, cable systems, and rigid fixation systems to Zimmer Biomet’s Dental, Spine & Craniomaxillofacial and Thoracic business.
The Phase III clinical trial showed a noticeable placebo effect compared with OV101.
The company will invest $1.2bn over the next four years to expand and upgrade its manufacturing capacity for pre-fillable syringes and advanced drug delivery systems across seven manufacturing facilities.